MD - MEDNAX, Inc.

NYSE - NYSE Delayed Price. Currency in USD
25.57
-0.39 (-1.50%)
At close: 4:03PM EDT
Stock chart is not supported by your current browser
Previous Close25.96
Open25.97
Bid25.50 x 1100
Ask0.00 x 900
Day's Range25.47 - 26.26
52 Week Range25.47 - 53.17
Volume1,205,055
Avg. Volume1,175,443
Market Cap2.196B
Beta (3Y Monthly)1.05
PE Ratio (TTM)8.73
EPS (TTM)2.93
Earnings DateApr 29, 2019 - May 3, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est38.54
Trade prices are not sourced from all markets
  • Wall Street Has Given Up on These 3 Stocks, and That's a Huge Mistake
    Motley Fool4 days ago

    Wall Street Has Given Up on These 3 Stocks, and That's a Huge Mistake

    Sometimes, the market gives up on businesses that still have some life left in them.

  • Business Wire6 days ago

    MEDNAX 2019 First Quarter Conference Call/Webcast Scheduled for Thursday, May 2, 2019

    MEDNAX, Inc. (MD), will host an investor conference call and webcast on Thursday, May 2, 2019 at 10:00 a.m. ET, to discuss results from operations for the three months ended March 31, 2019. The investor conference call will be webcast and can be accessed at MEDNAX’s website, www.mednax.com/investors. MEDNAX, Inc. is a national health solutions partner comprised of the nation's leading providers of physician services.

  • Markit14 days ago

    See what the IHS Markit Score report has to say about MEDNAX Inc.

    MEDNAX Inc NYSE:MDView full report here! Summary * ETFs holding this stock are seeing positive inflows * Bearish sentiment is low * Economic output in this company's sector is expanding Bearish sentimentShort interest | PositiveShort interest is low for MD with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | PositiveETF activity is positive. Over the last month, ETFs holding MD are favorable with net inflows of $70.26 billion. This was the highest net inflow seen over the last one-year.Error parsing the SmartText Economic sentimentPMI by IHS Markit | PositiveAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, and is accelerating. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • What Are Analysts Saying About MEDNAX, Inc.'s (NYSE:MD) Earnings Outlook?
    Simply Wall St.14 days ago

    What Are Analysts Saying About MEDNAX, Inc.'s (NYSE:MD) Earnings Outlook?

    Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! The latest earnings release MEDNAX, Inc.'s (NYSE:MD) announced in December 2018 showed that the...

  • GuruFocus.com15 days ago

    Stocks That Fell to 3-Year Lows in the Week of April 5

    CVS Health Corp, Walgreens Boots Alliance Inc., Mednax Inc. and Amdocs Ltd. have declined to their respective three-year lows

  • MEDNAX Ties Up With Georgia Neonatology for Better Baby Care
    Zacks21 days ago

    MEDNAX Ties Up With Georgia Neonatology for Better Baby Care

    MEDNAX (MD) forms a partnership with Georgia Neonatology, LLC to improve its pediatric services.

  • Business Wire25 days ago

    Georgia Neonatology Practice Joins MEDNAX

    MEDNAX, Inc. (MD), today announced its affiliation with Georgia Neonatology, LLC, a private neonatology practice based in Athens, Ga. Georgia Neonatology has provided neonatology services to Piedmont Healthcare’s Piedmont Athens Regional Medical Center location since 2013. The practice specializes in neonatal care for pre-term newborns and critically ill babies.

  • Business Wire26 days ago

    MEDNAX Announces Board of Directors Nominees

    MEDNAX, Inc. (MD), the national health solutions partner specializing in neonatology, anesthesiology, radiology, maternal-fetal medicine, other pediatric services, and management services, today announced the nomination of Carlos A. Migoya and Michael A. Rucker to stand for election to the Company’s Board of Directors at its Annual Meeting of Shareholders on May 16, 2019. As previously announced, MEDNAX’s Board and its Nominating and Corporate Governance Committee initiated a process, with the support of the nationally-recognized executive search firm Spencer Stuart, to evaluate the Board’s composition and identify additional director candidates to help drive MEDNAX’s strategy.

  • GuruFocus.comlast month

    Stocks That Fell to 3-Year Lows in the Week of March 22

    UBS Group AG (UBS), AutoNation Inc. (AN), Mednax Inc. (MD) and Amdocs Ltd. (DOX) have declined to three-year lows. The price of UBS Group shares declined to $11.88 on March 22, which is only 2.3% above the three-year low of $11.61. UBS is a Swiss investment bank and financial services company.

  • Moody'slast month

    MEDNAX, Inc. -- Moody's announces completion of a periodic review of ratings of MEDNAX, Inc.

    Announcement: Moody's announces completion of a periodic review of ratings of MEDNAX, Inc. New York, March 22, 2019 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of MEDNAX, Inc. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.

  • Why Is Mednax (MD) Down 17.6% Since Last Earnings Report?
    Zackslast month

    Why Is Mednax (MD) Down 17.6% Since Last Earnings Report?

    Mednax (MD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Did Changing Sentiment Drive MEDNAX’s Share Price Down By 50%?
    Simply Wall St.2 months ago

    Did Changing Sentiment Drive MEDNAX’s Share Price Down By 50%?

    Many investors define successful investing as beating the market average over the long term. But its virtually certain that sometimes you will buy stocks that fall short of the marketRead More...

  • GlobeNewswire2 months ago

    Report: Exploring Fundamental Drivers Behind IHS Markit, Mednax, HFF, Scientific Games, El Pollo Loco, and Plexus — New Horizons, Emerging Trends, and Upcoming Developments

    NEW YORK, Feb. 26, 2019 -- In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders,.

  • Business Wire2 months ago

    MedData's New RCM Technology Solution Accelerates Reimbursement for Providers

    MedData, a MEDNAX (MD) company and a leading provider of technology-enabled management services for hospitals and healthcare providers, today announced the launch of MedData FastTrack, a tech-infused solution for faster reimbursement. “Physicians and physician practices want a faster, less complicated method of medical coding and billing that helps maintain a steady stream of cash in the door,” said MedData President and COO Emily Fisher.

  • Business Wire2 months ago

    MEDNAX Announces Closing of $500 Million of 6.250% Senior Notes Due 2027

    MEDNAX, Inc. (MD), announced today the closing of the previously announced private placement of $500 million aggregate principal amount of its 6.250% senior notes due January 15, 2027 (the “Notes”). The completed transaction resulted in approximately $491.7 million in net proceeds to MEDNAX, which will be used to repay a portion of the indebtedness outstanding under its senior unsecured revolving credit facility. The Notes were offered to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and outside the United States to persons other than U.S. persons in reliance upon Regulation S under the Securities Act.

  • Business Wire2 months ago

    MEDNAX to Present at Upcoming Investor Conferences

    MEDNAX, Inc. , today announced that it is scheduled to make presentations at two upcoming investor conferences.

  • Business Wire2 months ago

    MEDNAX Announces Pricing of $500 Million of 6.250% Senior Notes Due 2027

    The Notes were offered to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and outside the United States to persons other than U.S. persons in reliance upon Regulation S under the Securities Act.

  • Business Wire2 months ago

    MEDNAX Launches Private Offering of $200 Million of 6.250% Senior Notes Due 2027

    MEDNAX, Inc. (MD), announced today that it is proposing to issue $200 million aggregate amount of 6.250% senior notes due 2027 (the “Notes”) in a private offering that is exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). The Notes will be issued as additional notes under an indenture, dated as of December 8, 2015, as supplemented by Supplemental Indenture No. 5 thereto, dated as of November 13, 2018 (collectively, the “Indenture”), pursuant to which the Company previously issued $500 million in aggregate principal amount of its 6.250% senior notes due 2027 (the “Existing Notes”). If the offering is successfully completed, MEDNAX intends to use the net proceeds from the offering to repay a portion of the indebtedness outstanding under its senior unsecured revolving credit facility.

  • Our Take On MEDNAX, Inc.’s (NYSE:MD) CEO Salary
    Simply Wall St.2 months ago

    Our Take On MEDNAX, Inc.’s (NYSE:MD) CEO Salary

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! In 2003 Roger Medel was appointed CEORead More...

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of MD earnings conference call or presentation 7-Feb-19 3:00pm GMT

    Q4 2018 MEDNAX Inc Earnings Call

  • MEDNAX (MD) Q4 Earnings Surpass Estimates, Increase Y/Y
    Zacks2 months ago

    MEDNAX (MD) Q4 Earnings Surpass Estimates, Increase Y/Y

    Mednax's (MD) Q4 gains on revenue growth. However, the same is partly offset by rise in expenses.

  • Mednax Inc (MD) Q4 2018 Earnings Conference Call Transcript
    Motley Fool2 months ago

    Mednax Inc (MD) Q4 2018 Earnings Conference Call Transcript

    MD earnings call for the period ending December 31, 2018.

  • Mednax (MD) Q4 Earnings and Revenues Top Estimates
    Zacks2 months ago

    Mednax (MD) Q4 Earnings and Revenues Top Estimates

    Mednax (MD) delivered earnings and revenue surprises of 1.10% and 2.81%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?